Stocks slid Friday as Wall Street’s mood darkened on the heels of soft economic data.The Dow Jones Industrial Average recorded its worst day of the year, closing down 1.7%, while the S&P 500 and ...

With 2025 underway, the AFS Health Care team highlights some of the most pressing legal issues facing the health care industry this year.

President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive ...

More than 10% of the staff working for the federal Substance Abuse and Mental Health Services Administration were fired this ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

CBD products made from hemp are federally legal following the Agriculture Improvement Act, which Congress passed and signed into law in 2018. But CBD oil doesn’t have Food and Drug Administration (FDA ...

President Donald Trump late Wednesday directed the Centers for Medicare and Medicaid Services (CMS) to disband a committee to ...

Representative Vern Buchanan (R-FL) has introduced two pieces of bipartisan legislation to improve access to telehealth and ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

The CEO of the medical device lobby, AdvaMed, raised concerns over the cuts' impact on patient health and medical device innovation. Separately, the former administrator of CMS spoke up to caution ...